Foresite Sees Plenty Of Investor Interest In Biopharma As It Raises $173m Fund
New Raise Exceeds $150m Goal To Back Incubated Start-Ups
Executive Summary
With its new fund for companies emerging from Foresite Labs, Foresite Capital has raised more than $1bn in new venture capital during the past year to back life science and health care innovation.